Avecho Biotechnology Limited(DE:OEZ)
€0.01+0.00 (+9.09%)
DE:OEZ
Avecho Biotechnology Limited financials statements
€0.01
At close:+0.00 (+9.09%)
Avecho Biotechnology Limited (OEZ) Ratios
1 Followers
Avecho Biotechnology Limited Ratios
DE:OEZ's free cash flow for Q2 2026 was AU$-51.47K. For the 2026 fiscal year, DE:OEZ's free cash flow was decreased by AU$-2.00K and operating cash flow was AU$-49.47K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 9.95 | 2.81 | 8.30 | 3.82 | 6.91 |
| Quick Ratio | 9.94 | 2.73 | 8.19 | 3.29 | 6.63 |
| Cash Ratio | 6.58 | 1.39 | 6.53 | 1.97 | 4.69 |
| Solvency Ratio | -0.77 | -1.72 | -3.46 | -2.29 | -4.21 |
| Operating Cash Flow Ratio | 1.56 | -2.32 | -3.77 | -2.23 | -4.45 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -4.06 | -41.34 | -23.48 | -38.63 |
| Net Current Asset Value | AU$ 1.51M | AU$ 3.08M | AU$ 6.06M | AU$ 1.93M | AU$ 4.10M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.22 | 0.02 | 0.07 | 0.02 |
| Debt-to-Equity Ratio | 0.01 | 0.33 | 0.03 | 0.10 | 0.02 |
| Debt-to-Capital Ratio | 0.01 | 0.25 | 0.03 | 0.09 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 4.56 | 1.53 | 1.15 | 1.38 | 1.16 |
| Debt Service Coverage Ratio | -8.39 | -1.24 | -23.48 | -19.19 | -20.55 |
| Interest Coverage Ratio | -13.01 | -86.80 | -298.84 | -482.60 | -456.24 |
| Debt to Market Cap | 0.00 | 0.16 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.79 | 0.44 | 1.64 | 0.58 | 1.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 60.70% | 59.31% | -9.25% | 70.25% | 64.00% |
| EBIT Margin | -485.09% | -270.52% | -722.41% | -206.91% | -429.18% |
| EBITDA Margin | -474.02% | -257.72% | -684.83% | -186.54% | -375.25% |
| Operating Profit Margin | -485.09% | -437.69% | -969.06% | -271.39% | -573.46% |
| Pretax Profit Margin | -518.07% | -275.55% | -952.80% | -262.62% | -572.20% |
| Net Profit Margin | -356.82% | -275.55% | -725.79% | -207.44% | -430.44% |
| Continuous Operations Profit Margin | -356.82% | -275.55% | -725.79% | -207.44% | -430.44% |
| Net Income Per EBT | 68.88% | 100.00% | 76.17% | 78.99% | 75.23% |
| EBT Per EBIT | 106.80% | 62.96% | 98.32% | 96.77% | 99.78% |
| Return on Assets (ROA) | -62.15% | -62.48% | -46.96% | -70.00% | -65.12% |
| Return on Equity (ROE) | -283.18% | -95.48% | -53.89% | -96.58% | -75.30% |
| Return on Capital Employed (ROCE) | -93.86% | -150.89% | -70.86% | -117.84% | -100.02% |
| Return on Invested Capital (ROIC) | -64.50% | -54.30% | -52.71% | -88.27% | -72.68% |
| Return on Tangible Assets | -62.15% | -62.48% | -46.96% | -70.56% | -66.41% |
| Earnings Yield | -15.02% | -50.00% | -50.51% | -8.66% | -12.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.56 | 0.50 | 0.43 | 1.51 | 0.70 |
| Payables Turnover | 4.69 | 7.60 | 5.45 | 1.76 | 3.80 |
| Inventory Turnover | 60.31 | 3.35 | 5.33 | 0.84 | 1.45 |
| Fixed Asset Turnover | 36.73 | 6.63 | 1.50 | 2.41 | 2.36 |
| Asset Turnover | 0.17 | 0.23 | 0.06 | 0.34 | 0.15 |
| Working Capital Turnover Ratio | 0.26 | 0.24 | 0.11 | 0.36 | 0.26 |
| Cash Conversion Cycle | 578.31 | 784.57 | 849.07 | 470.06 | 673.64 |
| Days of Sales Outstanding | 650.09 | 723.71 | 847.51 | 241.18 | 518.34 |
| Days of Inventory Outstanding | 6.05 | 108.89 | 68.52 | 436.49 | 251.37 |
| Days of Payables Outstanding | 77.83 | 48.03 | 66.96 | 207.60 | 96.06 |
| Operating Cycle | 656.14 | 832.60 | 916.03 | 677.67 | 769.71 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -635991.00 | -31.35 | -15.28 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -635991.00 | -31.35 | -15.28 |
| Operating Cash Flow Coverage Ratio | 76.22 | -3.69 | -18.16 | -6.77 | -32.99 |
| Operating Cash Flow to Sales Ratio | 0.89 | -3.50 | -6.72 | -1.47 | -3.90 |
| Free Cash Flow Yield | 3.75% | -63.56% | -46.73% | -6.35% | -12.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.43 | -2.00 | -1.98 | -11.55 | -7.91 |
| Price-to-Sales (P/S) Ratio | 23.75 | 5.51 | 14.37 | 23.96 | 34.07 |
| Price-to-Book (P/B) Ratio | 18.85 | 1.91 | 1.07 | 11.15 | 5.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 26.65 | -1.57 | -2.14 | -15.74 | -8.19 |
| Price-to-Operating Cash Flow Ratio | 26.65 | -1.57 | -2.14 | -16.24 | -8.72 |
| Price-to-Earnings Growth (PEG) Ratio | -0.16 | 0.06 | -0.13 | 0.37 | -0.67 |
| Enterprise Value Multiple | -4.22 | -1.69 | -0.45 | -12.26 | -8.01 |
| Enterprise Value | 24.75M | 4.95M | 1.48M | 25.83M | 23.86M |
| EV to EBITDA | -4.22 | -1.69 | -0.45 | -12.26 | -8.01 |
| EV to Sales | 20.00 | 4.37 | 3.11 | 22.88 | 30.07 |
| EV to Free Cash Flow | 22.44 | -1.25 | -0.46 | -15.03 | -7.23 |
| EV to Operating Cash Flow | 22.44 | -1.25 | -0.46 | -15.51 | -7.70 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.31 | 0.52 | 0.24 | 0.21 | 0.25 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 0.69 | 1.00 | 0.76 | 0.79 | 0.75 |
| Interest Burden | 1.07 | 1.02 | 1.32 | 1.27 | 1.33 |
| Research & Development to Revenue | 3.48 | 3.17 | 4.47 | 1.41 | 2.69 |
| SG&A to Revenue | 1.97 | 1.80 | 5.13 | 1.32 | 3.56 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.22 | 0.18 | 0.70 |
| Income Quality | -0.25 | 1.27 | 0.93 | 0.71 | 0.91 |
Currency in AUD
